Related Experiment Video
Updated: Jan 10, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
Published on: September 1, 2023
Synergistic effect of LTB and Mn2+ adjuvants on immunogenicity of multi-epitope peptides from Staphylococcus aureus
Jinzhu Ma1, Shuyu Wei1, Ming Xu1
1College of Life Science and Technology, Heilongjiang Bayi Agricultural University, Daqing, 163319, China.
Here, a novel combined adjuvant of heat-labile enterotoxin B (LTB) as an intramolecular adjuvant plus Mn2+ was prepared to enhance the immunogenicity of multi-epitope (MEP) peptides derived from Staphylococcus aureus (S. aureus). Initially, the mep and ltb-mep fragments were amplified and inserted into pET-28a vectors, respectively, to generate the recombinant plasmids pET28a-mep and pET28a-ltb-mep. Then, the expression of MEP and LTB-MEP was verified by Western blot. Subsequently, the MEP and LTB-MEP proteins were subjected to bioinformatics analysis. Kunming mice were immunized with the LTB-MEP proteins plus Mn2+ adjuvants. After the second immunization, the mice immunized with LTB-MEP plus Mn2+ exhibited significantly enhanced splenic lymphocyte proliferation, increased secretion of IFN-β, IFN-γ, IL-2, IL-6, and IL-17 by splenic lymphocytes, and significantly enhanced the generation of antibodies against MEP in serum, and improved survival rate following S. aureus challenge. The data showed that the novel LTB-Mn2+ combined adjuvant exerted a synergistic effect, significantly enhanced the immunogenicity of MEP, and provided a new strategy for improving the efficacy of vaccines against S. aureus.
Here, a novel combined adjuvant of heat-labile enterotoxin B (LTB) as an intramolecular adjuvant plus Mn2+ was prepared to enhance the immunogenicity of multi-epitope (MEP) peptides derived from Staphylococcus aureus (S. aureus). Initially, the mep and ltb-mep fragments were amplified and inserted into pET-28a vectors, respectively, to generate the recombinant plasmids pET28a-mep and pET28a-ltb-mep. Then, the expression of MEP and LTB-MEP was verified by Western blot. Subsequently, the MEP and LTB-MEP proteins were subjected to bioinformatics analysis. Kunming mice were immunized with the LTB-MEP proteins plus Mn2+ adjuvants. After the second immunization, the mice immunized with LTB-MEP plus Mn2+ exhibited significantly enhanced splenic lymphocyte proliferation, increased secretion of IFN-β, IFN-γ, IL-2, IL-6, and IL-17 by splenic lymphocytes, and significantly enhanced the generation of antibodies against MEP in serum, and improved survival rate following S. aureus challenge. The data showed that the novel LTB-Mn2+ combined adjuvant exerted a synergistic effect, significantly enhanced the immunogenicity of MEP, and provided a new strategy for improving the efficacy of vaccines against S. aureus.
More Related Videos
06:57Author Spotlight: Adjuvant Activity of Mycobacterium paratuberculosis in Enhancing the Immunogenicity of Autoantigens During Experimental Autoimmune Encephalomyelitis
Published on: May 12, 2023
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Microorganisms in Medicine and Therapeutics